Could This Cancer Test Be a Game-Changer?

I don’t need to tell you that being diagnosed with cancer is a nightmare.

And the nightmare gets worse if you learn that your cancer was not caught early.

When it comes to cancer, the sooner you catch it, the better your chances of survival.

The deadliest cancers—like pancreatic cancer, for example—are so lethal because they’re typically not detected until they’re already advanced.

Bladder cancer, which kills approximately one in five people who are diagnosed, is one particular cancer where the survival rate could be improved with better testing.

Now, scientists say they’re on the verge of a non-invasive test that could detect bladder cancer years sooner than anything else on the market.

And it could be a life-saving game-changer for you and the people you love.

The current tests for bladder cancer are invasive and expensive.

But a new diagnostic test detailed in a study published in The Lancet could finally put a dent in the bladder cancer statistics.

Scientists developed a simple urine test that can detect bladder cancer up to 10 years before any symptoms develop.

We might be talking about the potential to save tens of thousands of lives per year.

This test identifies mutations in the TERT (telomerase reverse transcriptase) gene, which are the most common mutations seen in bladder cancer.

Their initial evaluation of the test showed that it detected the biomarkers for bladder cancer in about 47 percent of the people who later developed bladder cancer.

Those changes were detected up to 10 years before people received a clinical diagnosis.

That’s a remarkable result that represents a major step in bladder cancer detection.

If this test is verified in clinical trials, it could offer a non-invasive, low-cost testing option for people at high risk of developing bladder cancer.

It’s not often that we see new tests that could have this level of impact. I’ll be following this story closely and will bring you more updates as soon as I have them.